The present invention relates to gas-enhanced electrosurgical systems, and more particularly, to a system and method for voice-control of a gas-enhanced electrosurgical system and other electronic operating room equipment combined with an augmented reality display system.
A variety of different electrosurgical generators are known. U.S. Pat. No. 4,429,694 to McGreevy disclosed an electrosurgical generator and argon plasma system and a variety of different electrosurgical effects that can be achieved depending primarily on the characteristics of the electrical energy delivered from the electrosurgical generator. The electrosurgical effects included pure cutting effect, a combined cutting and hemostasis effect, a fulguration effect and a desiccation effect. Fulguration and desiccation sometimes are referred to collectively as coagulation.
Another method of monopolar electrosurgery via argon plasma technology was described by Morrison in U.S. Pat. No. 4,040,426 in 1977 and McGreevy U.S. Pat. No. 4,781,175. This method, referred to as argon plasma coagulation (APC) or argon beam coagulation is a non-contact monopolar thermoablative method of electrocoagulation that has been widely used in surgery for the last twenty years. In general, APC involves supplying an ionizable gas such as argon past the active electrode to target tissue and conducting electrical energy to the target tissue in ionized pathways as non-arcing diffuse current. Canady described in U.S. Pat. No. 5,207,675 the development of APC via a flexible catheter that allowed the use of APC in endoscopy. These new methods allowed the endoscopist to combine standard monopolar electrocautery with a plasma gas for coagulation of tissue.
Yet another system is disclosed in U.S. Patent Application Publication No. 2013/0296846, which disclosed a system for simultaneously cutting and coagulating tissue. Another system, referred to as a “cold atmospheric plasma” system, is disclosed in U.S. Patent Application Publication No. 2014/0378892.
Several different systems and methods for performing Cold Atmospheric Plasma (CAP) treatment have been disclosed. For example, U.S. Pat. No. 10,213,614 discloses a two-electrode system for CAP treatement of cancer cells.
Another exemplary Cold Atmospheric Plasma system is disclosed in U.S. Pat. No. 9,999,462. The disclosed system has two units, namely a Conversion Unit (CU) and a Cold Plasma Probe (CPP). The Conversion Unit is connected to high frequency electrosurgical generator (ESU) output and converts the ESU signal to a signal appropriate for performing cold atmospheric plasma procedures. The Cold Plasma Probe is connected to the Conversion Unit output. At the end of the Cold Plasma Probe cold plasma is produced and is thermally harmless to living tissue, i.e., it cannot cause burns to the tissue. This cold plasma, however, is deadly for cancer cells while leaving normal cells unaffected. The disclosed Cold Plasma Conversion Unit is unique in that it utilizes a high voltage transformer to up-convert the voltage (1.5-50 kV), down-convert the frequency (<300 kHz), and down-convert the power (<30 W) of the high-voltage output from an electrosurgical unit (U.S. Pat. No. 9,999,462).
Further, various systems and methods for controlling gas flow and an integrated gas-assisted electrosurgical generator having a graphical user interface is disclosed in WO2018/191265, entitled “Electrosurgical Gas Control Module” and WO2019199281, entitled “Gas Enhanced Electrosurgical Generator.”
Various additional systems and methods for assisting surgeons in controlling surgical systems have been disclosed, including the following:
U.S. Published Patent Application No. 20200219324 entitled “Surgeon Head- Mounted Display Apparatuses”;
U.S. Published Patent Application No. 20200211420 entitled “System And Method For Three-Dimensional Augmented Reality Guidance For Use Of Medical Equipment”; and
U.S. Published Patent Application No. 20200107904 entitled “System And Method For Virtual Reality Data Integration And Visualization For 3d Imaging And Instrument Position Data”.
In a preferred embodiment, the present invention is an electrosurgical system and method for control of an electrosurgical system with an enhanced reality display system wirelessly connected to the gas-enhanced electrosurgical system. The electrosurgical system comprises a gas-enhanced electrosurgical generator, a voice- recognition system connected to said gas-enhanced electrosurgical generator, a robotic system, and an enhanced reality display system wirelessly connected to said gas-enhanced electrosurgical system. The gas-enhanced electrosurgical generator may comprise a power module, a gas control module, and a control module, wherein said control module is configured to provide voice control of said power module and said gas module.
In another embodiment, the present invention is a method for operating an electrosurgical system using an enhanced reality display.
Still other aspects, features, and advantages of the present invention are readily apparent from the following detailed description, simply by illustrating preferable embodiments and implementations. The present invention is also capable of other and different embodiments and its several details can be modified in various obvious respects, all without departing from the spirit and scope of the present invention. Accordingly, the drawings and descriptions are to be regarded as illustrative in nature and not as restrictive. Additional objects and advantages of the invention will be set forth in part in the description which follows and in part will be obvious from the description or may be learned by practice of the invention.
For a more complete understanding of the present invention and the advantages thereof, reference is now made to the following description and the accompanying drawings, in which:
A method for voice activation of electronic equipment in an operating room in accordance with a preferred embodiment of the present invention is described with reference to
The transmitted encrypted commend is received at the electronic equipment, which decodes the comments 132 and determines whether the decoded command is valid 130. If the decoded command is valid, the electronic equipment performs a safety evaluation 150 to ensure that the command can be safely executed. If the decoded command is deemed to be safe, the command is executed by the electronic equipment and the user is notified verbally or visually that the command has been executed. If the command is not deemed to be safe, the user is notified 154 visually or verbally.
A method for voice activation of electronic equipment in an operating room in accordance with a preferred embodiment of the present invention is further shown in the detailed flow diagram of
Further, a system for voice activation of electronic equipment in an operating room in accordance with a preferred embodiment of the present invention is shown in
The system and method of the present invention may be used with a variety of electronic equipment used in an operating room. One such system is a cold atmospheric plasma system. As shown in
As shown in
Another embodiment, shown in
A housing 500 for a CAP-enabled gas-enhanced electrosurgical generator 500 in accordance with a preferred embodiment of the present invention is shown in
On the face of the housing 514 there is a touch-screen display 520 and a plurality of connectors 532, 534 for connecting various accessories to the generator, such as an argon plasma probe, a hybrid plasma probe, a cold atmospheric plasma probe, or any other electrosurgical attachment. The face of the housing 510 is at an angle other than 90 degrees with respect to the top and bottom of the housing 510 to provide for easier viewing and use of the touch screen display 520 by a user. One or more of the gas control modules may be mounted within a gas-enhanced electrosurgical generator 500.
The CAP-enabled gas-assisted electrosurgical generator has a graphical user interface (GUI) for controlling the components of the system using the touch screen display 520. The graphical user interface for example, may control robotics, argon-monopolar cut/coag, hybrid plasma cut, cold atmospheric plasma, bipolar, plasma sealer, hemo dynamics or voice activation. The graphical user interface further may be used with fluorescence-guided surgery. The graphical user interface (GUI) further may be used with guided imaging such as CT, MRI, or ultrasound. The graphical user interface may communicate with RFID (such as may be found in various electrosurgical attachments) and may collect and store usage data in a storage medium. The graphical user interface communicates with the field-programmable gate array (“FPGA”), which may control an irrigation pump, insufflator, full bridge for adjusting the power output, fly back for regulating the power (DC to AC) and a foot pedal. The GUI further communicates with a database of data with associated predicted CAP settings or dosages via the CPU 410. The database storage may be internal memory or other internal storage 411 or external storage.
The foregoing description of the preferred embodiment of the invention has been presented for purposes of illustration and description. It is not intended to be exhaustive or to limit the invention to the precise form disclosed, and modifications and variations are possible in light of the above teachings or may be acquired from practice of the invention. The embodiment was chosen and described in order to explain the principles of the invention and its practical application to enable one skilled in the art to utilize the invention in various embodiments as are suited to the particular use contemplated. It is intended that the scope of the invention be defined by the claims appended hereto, and their equivalents. The entirety of each of the aforementioned documents is incorporated by reference herein.
The present application is a continuation-in-part of U.S. Non-provisional patent application Ser. No. 17/471,828 filed on Sep. 20, 2021, which claims the benefit of the filing date of U.S. Provisional Patent Application Ser. No. 63/076,771 filed on Sep. 20, 2020. The present application further claims the benefit of the filing date of U.S. Provisional Patent Application Ser. No. 63/339,631 filed by the present inventors on May 9, 2022. The aforementioned patent applications are hereby incorporated by reference in their entirety.
Number | Date | Country | |
---|---|---|---|
63339631 | May 2022 | US | |
63076771 | Sep 2020 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 17471828 | Sep 2021 | US |
Child | 18195164 | US |